# Orca Biosystems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/orca-biosystems

- Industry: Biotechnology
- Headquarters: Menlo Park, US
- Website: www.orcabio.com
- Total disclosed funding: $360M
- Latest round: Series F (Dec 31, 2025)
- Investors on record: 9

## About

Founded in 2016 and based in California, US, Orca Biosystems Inc. operates as a biotechnology company that researches and develops cell therapies for allogeneic bone marrow transplant procedure (alloBMT) procedures.

## Funding rounds

- Series F, Dec 31, 2025, $168M — Lightspeed Venture Partners
- Series D, Nov 29, 2019, $192M — Blue Chip Venture Company, Lightspeed Venture Partners, Illinois Municipal Retirement Fund, +ND Capital, Mubadala Investment Company, Felicis Ventures, Kaiser Permanente Ventures, DCVC, 8VC

## Investors

- Blue Chip Venture Company (https://capitalatlas.ai/funds/blue-chip-venture-company) — Series D
- Lightspeed Venture Partners (https://capitalatlas.ai/funds/lightspeed-venture-partners) — Series D, Series F
- Illinois Municipal Retirement Fund — Series D
- +ND Capital (https://capitalatlas.ai/funds/nd-capital) — Series D
- Mubadala Investment Company — Series D
- Felicis Ventures (https://capitalatlas.ai/funds/felicis-ventures) — Series D
- Kaiser Permanente Ventures (https://capitalatlas.ai/funds/kaiser-permanente-ventures) — Series D
- DCVC (https://capitalatlas.ai/funds/dcvc) — Series D
- 8VC (https://capitalatlas.ai/funds/8vc) — Series D